StockData
Connect Biopharma Holdings Ltd logo

Connect Biopharma Holdings Ltd (CNTB) stock

CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.63−0.04 (-5.56%)

Close on Nov 19, 2026Market cap $39.56MP/E –Yield –

Connect Biopharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Connect Biopharma's free cash flow for the twelve months ending Jun 30, 2026 was -$60.63M. For fiscal 2025 it was -$51.64M. The highest annual figure on record is -$24.36M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$51.64M–
FY2024Dec 31, 2024-$24.36M–
FY2023Dec 31, 2023-$47.82M–
FY2022Dec 31, 2022-$105.93M–
FY2021Dec 31, 2021-$88.16M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$15.92M–
Q1 FY2026Mar 31, 2026-$16.01M–
Q4 FY2025Dec 31, 2025-$11.27M–
Q3 FY2025Sep 30, 2025-$17.44M–
Q2 FY2025Jun 30, 2025-$12.89M–
Q1 FY2025Mar 31, 2025-$10.04M–
Q4 FY2024Dec 31, 2024-$2.63M–
Q3 FY2024Sep 30, 2024-$13.15M–
Q2 FY2024Jun 30, 2024-$7.99M–
Q1 FY2024Mar 31, 2024-$591.00K–

More Connect Biopharma figures

See a number that looks wrong?